The Long Run with Luke Timmerman Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery
May 1, 2024
Vineeta Agarwala, a general partner at A16Z's Bio & Health fund, discusses AI's impact on drug discovery. Topics include AI automating tasks, learning from negative data, and the hype around AI in healthcare. She emphasizes the importance of small startups in curating data for AI, the necessity of patience in biotech investments, and the future of collaborative learning in drug discovery.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 2min
Biotech Industry Innovators
01:43 • 5min
Investment Philosophy and Focus on Patient Impact in Biotech and Healthcare
06:39 • 3min
AI in Therapeutic Innovation and Drug Discovery
09:25 • 18min
Biotech Investing Patience and Promotions
27:25 • 2min
Balancing Clinical Practice and Biotech Decisions
29:21 • 24min
Envisioning a Future of Collaborative Learning and Technological Advancement in Drug Discovery
52:57 • 4min